Abstract Coronavirus disease 2019 (COVID-19), an infectious disease caused by the novel
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic that …

COVID-19 is a highly transmissible disease caused by severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), affects 226 countries and continents, and has resulted in> 6.2 …

Background SARS-CoV-2 induces a spectrum of clinical conditions ranging from
asymptomatic infection to life threatening severe disease. Host microRNAs have been …

Abstract The coronavirus disease 2019 (COVID-19) pandemic has been looming globally for
three years, yet the diagnostic and treatment methods for COVID-19 are still undergoing …

Background As the therapeutic regimens against the COVID-19 remain scarce, the
microRNAs (miRNAs) can be exploited to generate efficient therapeutic targets. The miRNAs …

The plasma levels of tissue-specific microRNAs can be used as diagnostic, disease severity
and prognostic biomarkers for chronic and acute diseases and drug-induced injury …

COVID-19 is a global pandemic impacting the daily living of millions. As variants of the virus
evolve, a complete comprehension of the disease and drug targets becomes a decisive …

The stratification of mortality risk in COVID-19 patients remains extremely challenging for
physicians, especially in older patients. Innovative minimally invasive molecular biomarkers …

ABSTRACT SARS-CoV-2 tropism for the ACE2 receptor, along with the multifaceted
inflammatory reaction, is likely to drive the generalized hypercoagulable and thrombotic …

Abstract miRNAs are single‐stranded ncRNAs that act as regulators of different human body
processes. Several miRNAs have been noted to control the human immune and …